Stoke Therapeutics STOK
NASDAQ STOK
$25.62 -0.39 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Stoke Therapeutics (STOK) reported Return on Capital Employed [ROCE] of -59.30% for Q2 2026, down 70.58 percentage points from 11.28% a year earlier and down 11.81 percentage points from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Stoke Therapeutics posted Return on Capital Employed [ROCE] of -7.17%, up 41.13 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +13.89 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -48.30% in FY2024 (+6.00 pp), -54.30% in FY2023 (-6.00 pp), -48.30% in FY2022 (-14.04 pp) and -34.25% in FY2021 (-13.20 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in six of the last eight quarters, with an average year-over-year change of +15.18 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2025 (a gain of 78.37 percentage points); the low point was Q2 2026 (a drop of 70.58 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -47.49% (Q1 2026), -6.21% (Q4 2025) and 8.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Stoke Therapeutics 1.60 Bn 429.41 Mn - -59.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.30%
Mar 31, 2026 -47.49%
Dec 31, 2025 -6.21%
Sep 30, 2025 8.22%
Jun 30, 2025 11.28%
Mar 31, 2025 12.98%
Dec 31, 2024 -41.82%
Sep 30, 2024 -46.80%
Jun 30, 2024 -54.03%
Mar 31, 2024 -65.38%
Dec 31, 2023 -56.46%
Sep 30, 2023 -50.34%
Jun 30, 2023 -45.36%
Mar 31, 2023 -43.91%
Dec 31, 2022 -44.32%
Sep 30, 2022 -39.01%
Jun 30, 2022 -34.60%
Mar 31, 2022 -36.95%
Dec 31, 2021 -37.55%
Sep 30, 2021 -30.79%
API Access

Stoke Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=STOK&period=max&api_key=YOUR_API_KEY